Phoenix Financial Ltd. decreased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 65.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,322 shares of the exchange traded fund’s stock after selling 10,200 shares during the quarter. Phoenix Financial Ltd.’s holdings in SPDR S&P Biotech ETF were worth $649,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Legacy Wealth Managment LLC ID acquired a new stake in SPDR S&P Biotech ETF during the fourth quarter worth about $32,000. Ballast Advisors LLC bought a new position in SPDR S&P Biotech ETF in the 4th quarter worth about $36,000. Barnes Dennig Private Wealth Management LLC bought a new position in SPDR S&P Biotech ETF in the 4th quarter worth about $48,000. Navalign LLC bought a new position in SPDR S&P Biotech ETF in the 4th quarter worth about $48,000. Finally, Citizens National Bank Trust Department bought a new position in SPDR S&P Biotech ETF in the 4th quarter worth about $50,000.
SPDR S&P Biotech ETF Trading Down 3.1%
NYSEARCA XBI opened at $130.69 on Friday. SPDR S&P Biotech ETF has a 52 week low of $77.33 and a 52 week high of $139.19. The stock has a market cap of $8.34 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85. The company has a 50-day moving average price of $129.38 and a two-hundred day moving average price of $124.41.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Read More
- Five stocks we like better than SPDR S&P Biotech ETF
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
